Catalysts for Tehran University of Medical Sciences
2 tracked
Apr 26, 2026
phase 3 completion
Tehran University of Medical Sciences — diltiazem (Phase III Trial Completion)
diltiazem
→
Apr 25, 2026
phase 2 completion
Tehran University of Medical Sciences — FOLFOX [leucovorin + fluorouracil + oxaliplatin] (Phase II Trial Completion)
FOLFOX [leucovorin + fluorouracil + oxaliplatin]
→